Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Scott

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Molecular Therapy. Methods & Clinical Development|April 1, 2024
Novel AAV variants with improved tropism for human Schwann cellsMatthieu Drouyer, Tak-Ho Chu, Elodie Labit, et al.
Molecular Therapy. Methods & Clinical Development|January 3, 2022
Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8Marti Cabanes-Creus, Renina Gale Navarro, Erhua Zhu, et al.
Molecular Therapy. Methods & Clinical Development|January 26, 2023
Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistributionMarti Cabanes-Creus, Renina Gale Navarro, Sophia H Y Liao, et al.
Science Translational Medicine|September 10, 2020
Restoring the natural tropism of AAV2 vectors for human liverMarti Cabanes-Creus, Claus V Hallwirth, Adrian Westhaus, et al.
Molecular Therapy. Methods & Clinical Development|June 4, 2020
Attenuation of Heparan Sulfate Proteoglycan Binding Enhances <i>In Vivo</i> Transduction of Human Primary Hepatocytes with AAV2Marti Cabanes-Creus, Adrian Westhaus, Renina Gale Navarro, et al.
Molecular Therapy. Methods & Clinical Development|September 7, 2023
Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytesCindy Y Kok, Shinya Tsurusaki, Marti Cabanes-Creus, et al.
Human Gene Therapy|March 17, 2023
Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus VectorsAdrian Westhaus, Marti Cabanes-Creus, Kimberley L Dilworth, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Molecular Therapy. Methods & Clinical Development|April 1, 2024
Novel AAV variants with improved tropism for human Schwann cellsMatthieu Drouyer, Tak-Ho Chu, Elodie Labit, et al.
Molecular Therapy. Methods & Clinical Development|January 3, 2022
Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8Marti Cabanes-Creus, Renina Gale Navarro, Erhua Zhu, et al.
Molecular Therapy. Methods & Clinical Development|January 26, 2023
Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistributionMarti Cabanes-Creus, Renina Gale Navarro, Sophia H Y Liao, et al.
Science Translational Medicine|September 10, 2020
Restoring the natural tropism of AAV2 vectors for human liverMarti Cabanes-Creus, Claus V Hallwirth, Adrian Westhaus, et al.
Molecular Therapy. Methods & Clinical Development|June 4, 2020
Attenuation of Heparan Sulfate Proteoglycan Binding Enhances <i>In Vivo</i> Transduction of Human Primary Hepatocytes with AAV2Marti Cabanes-Creus, Adrian Westhaus, Renina Gale Navarro, et al.
Molecular Therapy. Methods & Clinical Development|September 7, 2023
Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytesCindy Y Kok, Shinya Tsurusaki, Marti Cabanes-Creus, et al.
Human Gene Therapy|March 17, 2023
Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus VectorsAdrian Westhaus, Marti Cabanes-Creus, Kimberley L Dilworth, et al.
Pageof 6